Decline in estimated glomerular filtration rate following substitution of Nevirapine-based regimen with Tenofovir-based regimen in Indonesia

Abstract Background Indonesia started transitioning people living with HIV (PLHIV) from Nevirapine (NVP)-based antiretroviral therapy to tenofovir (TDF)-lamivudine-dolutegravir fixed-dose combination (TLD) in 2023. We aimed to evaluate changes in estimated glomerular filtration rate (eGFR) and predi...

Descripció completa

Dades bibliogràfiques

Autors principals:	Evy Yunihastuti, Pringgodigdo Nugroho, Muhammad Yusuf, Salfia Dian Lastari, Fadlika Harinda, Tiara Kumala Putri, Meivina Ramadhani Pane, Metra Adi Pratama, Mira Yulianti, Alvina Widhani, Suzy Maria, Anshari Saifuddin Hasibuan, Maruhum Bonar Hasiholan Marbun, Sukamto Koesnoe, Teguh Harjono Karjadi
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-10-01
Col·lecció:	BMC Infectious Diseases
Matèries:	Dolutegravir Drug substitution Kidney function Nevirapine Tenofovir ART
Accés en línia:	https://doi.org/10.1186/s12879-025-11710-y
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!